What Pharmaceutical Serialization Is and Why It Matters

Serialization is the requirement to place unique identifying information on pharmaceutical packaging so every individual unit can be tracked from manufacture to dispenser. It's not new, but enforcement has become increasingly strict.

The U.S. Drug Supply Chain Security Act (DSCSA) mandates serialization on all finished pharmaceutical products at the package level. The EU Falsified Medicines Directive (FMD) mandates serialization across the EU. Japan, Australia, and other regulated markets have parallel requirements. (FDA DSCSA Guidance, 2024)

The purpose is counterfeit prevention and rapid recall capability. If there's a quality issue, a contamination, or a counterfeit product in the supply chain, regulatory authorities need to identify and isolate affected units immediately.

This sounds straightforward until you're designing packaging. Every pharmaceutical unit needs a unique serial number. Every unit needs a lot number. Every unit needs an expiry date. These elements must be printed in human-readable format and also in 2D barcode format readable by automated systems.

The difference between supplement packaging and pharmaceutical packaging is this: Supplements need one version of your label design printed in thousands of units. Pharmaceuticals need thousands of slightly different versions because each unit has a unique serial number. Your label design must accommodate this variation without looking chaotic or amateur. (Pharmaceutical Packaging Professionals, 2024)

Primary vs. Secondary Packaging Serialization Requirements

Serialization requirements differ by packaging level and market.

Primary packaging is the package that directly contains the drug product. A blister pack of tablets. A bottle of liquid medication. A single-dose sachet. Primary packaging must include serialization in both human-readable and machine-readable formats. Secondary packaging is the outer carton or case that contains multiple units of primary packaging. A carton containing 10 blister packs. A shipping case containing 100 bottles. Secondary packaging must also include serialization for supply chain tracking.

In the U.S., DSCSA requires serialization on both primary and secondary packaging. The identifiers must be present in human-readable format and in 2D barcode format. (U.S. Pharmacopeia, 2025)

In the EU, FMD requires serialization on the primary packaging of all prescription medicines. The unique identifier consists of a serial number, a lot number, and the expiry date. Non-prescription medicines in EU markets have less stringent requirements but serialization is still required.

The key difference: Primary packaging serialization directly affects patient experience and shelf impact because patients see it. Secondary packaging serialization is more about logistics but still affects how products move through pharmacies and distribution centers.

Your design strategy must address both because they represent different visual problems.

What Track-and-Trace Requires on the Label

Let's get specific about what elements must appear on pharmaceutical packaging.

2D Barcode: This is typically a QR code or Data Matrix code containing the product identifier, serial number, lot number, and expiry date in encoded format. The 2D barcode must be machine-readable by pharmacy automation and regulatory scanning systems. It typically measures 8x8 mm to 25x25 mm depending on the barcode type and label size.

The 2D barcode sounds small until you realize it's non-negotiable real estate on a label. On a small blister pack, 8x8 mm is significant. On a large carton, it's less of an issue but still takes up design space.

Human-Readable Serial Number: The serial number must appear in text format, not just in the 2D barcode. Font size requirements vary by market but typically minimum 7-8 pt depending on the font. This serial number takes up label real estate and must be positioned where it won't be obscured by folding, handling, or applying to shelving. Lot/Batch Number: Similarly required in human-readable format. Must be clearly differentiated from the serial number even though both identify the product. Expiry Date: Must appear in a specific format (MM/YYYY or DD/MM/YYYY depending on market). Must be human-readable and also encoded in the 2D barcode. Anti-Tampering Elements: Some markets require specific anti-tampering graphics or text on packaging. These are additional elements that consume label real estate.

For an OTC product sold in multiple markets, you might need this information in multiple languages, further consuming label space. (EudraLex Guideline on GCP, 2025)

The cumulative effect: These required elements occupy 15-25% of your available label surface area on primary packaging, depending on label size and barcode dimensions.

How Serialization Takes Up Label Real Estate

This is where design strategy becomes critical. You don't have the label space you think you do.

Consider a standard pharmaceutical bottle label: 4 inches wide x 3 inches tall (approximately). Your design space seems generous. Then you account for required elements:

Regulatory nutrition or supplement facts panel: 1.5" x 2" depending on claims.

2D barcode: 0.3" x 0.3"

Serial number: 0.3" x 0.1"

Lot number: 0.3" x 0.1"

Expiry date: 0.3" x 0.1"

Allergen statements: 0.2" x 0.5"

Warning statements: 0.2" x 0.4"

Mandatory text (directions, ingredients): 0.8" x 1"

You've now used 75% of your label area for mandatory elements. You have 1 square inch left for your brand name, product benefit statement, and brand identity elements.

The temptation is to shrink type sizes and compress spacing to fit everything. This creates packaging that looks cluttered, hard to read, and unprofessional.

A better approach is to account for serialization and mandatory elements from the beginning of your label design, not as an afterthought. You design around these constraints, not against them.

The Design Strategy for Serialization

How do you design pharmaceutical packaging that accommodates serialization without looking chaotic?

Strategy 1: Separate Information Hierarchy

Create a clear visual hierarchy where mandatory/regulatory information is separated from brand identity. The front of the label emphasizes brand name, product benefit, and visual identity. The back panel and side panels contain regulatory and serialization information.

This approach keeps your brand-facing surface clean while containing required information on less-visible surfaces. It's how luxury pharmaceutical brands manage the tension between regulatory requirements and brand aesthetics.

Strategy 2: High-Contrast Serialization Design

Make serialization elements distinctly visible through typography and color. Instead of hiding 2D codes and serial numbers as small, gray text, make them bold and high-contrast. This serves regulatory intent (clarity, readability) while also making the packaging look intentional rather than cluttered.

A strong 2D barcode in high-contrast against the label background signals transparency and compliance. It actually strengthens brand perception if executed well.

Strategy 3: Color-Coded Information Zones

Divide the label into distinct information zones with subtle color differentiation. Brand identity and benefits in one zone. Regulatory and serialization information in another. This visual organization makes it clear to customers that this is professional pharmaceutical packaging with proper controls.

Strategy 4: Micro-Typography and Modular Systems

Use modular label systems where serialization information is printed in a standardized location with standardized formatting. This reduces the apparent complexity of variable elements. All serial numbers appear in the same position with the same font and size, creating visual consistency despite the numbers being unique on each unit.

Strategy 5: Strategic Use of White Space

Don't fill every inch of label space with information. Strategic white space around serialization elements makes them less visually jarring. It also improves readability and creates a more premium visual impression.

Pharmaceutical packaging from luxury brands often looks cleaner because they use more white space, not less. This isn't wasteful. It's strategic design that makes compliance elements feel intentional rather than obligatory.

Serialization Requirements by Market

Serialization mandates differ by geography. If you're selling pharmaceuticals in multiple markets, you face multiple serialization systems.

The implications: You likely cannot design one label for all markets. You need market-specific designs or highly flexible label templates that accommodate different serialization systems.

Designing Pharmaceutical Packaging That Is Both Compliant and Brand-Coherent

The goal is packaging that doesn't look like a compliance document. It looks like a premium pharmaceutical product.

Start with serialization constraints before sketching.

Before your designer touches pen to paper, they need a clear understanding of which serialization elements are non-negotiable. 2D barcode size. Human-readable text sizes. Placement requirements. Language requirements.

These aren't optional. They shape the entire layout. A designer who learns about serialization requirements after creating the initial concept has wasted time.

Build a label grid that accommodates serialization.

Create a modular grid system where serialization information has designated zones. This prevents the appearance of information being randomly scattered. The grid should have one zone for brand identity, one for product benefits, one for regulatory information, one for serialization.

This grid system makes it easy to produce variations for different markets or serialization systems without redesigning from scratch each time.

Test serialization elements with actual printing specifications.

2D barcodes must be printed accurately to scan reliably. Test barcode printing on the actual substrate you're using. Test at the actual size you're proposing. Barcodes that are slightly under-sized or printed on materials that interfere with scanning fail in the field.

Similarly, human-readable serial numbers must be legible. Test the font and size you've chosen by printing samples and reading them at the distance a pharmacist or patient would view them.

Make serialization elements visually distinct but intentional.

Don't treat serialization as visual clutter. Make it a designed element. If you're using a Data Matrix code, position it prominently and pair it with clear labeling ("Scan here to verify authenticity" or similar). Make it obvious that this is security and compliance, not visual noise.

Plan for market-specific variations early.

If you're designing for multiple markets with different serialization requirements, create one master design and specific market variations that inherit from it. This reduces design time and ensures consistency across markets while accommodating market-specific rules.

A U.S. version might have one barcode placement. An EU version might have a slightly different barcode location due to FMD specifications. But they're clearly the same brand and product, just adapted to local requirements.

Common Serialization Design Mistakes

I see patterns in pharmaceutical packaging that got serialization design wrong.

Mistake 1: Adding serialization after the label design is complete.

The designer creates a beautiful label. Then you tell them they need a 2D barcode and serial number. They squeeze these into tiny spaces. The label goes from clean to cluttered. The barcode is too small to scan reliably.

Serialization must be part of the original design brief, not an add-on.

Mistake 2: Making serialization elements too small or low-contrast.

The designer decides serialization looks ugly so they make it as small and gray as possible. Regulators reject this. The barcode doesn't scan reliably. Patients can't read serial numbers.

Serialization must be designed to be readable and scannable, even if you don't love how it looks.

Mistake 3: Not testing barcode printing and scanning.

You design a label with a 2D barcode, print samples, and don't test whether the barcode actually scans reliably. You discover in production that the barcode format is slightly wrong or the substrate interferes with scanning.

Test serialization elements with actual printing specifications and automated scanning systems before finalizing your design.

Mistake 4: Ignoring market-specific requirements.

You design packaging for the U.S. market, then sell the same packaging in EU markets. The serialization format or placement violates EU FMD requirements. Your product is unprintable or legally non-compliant.

Verify serialization requirements for every market where you'll sell before finalizing your design.

Mistake 5: Making variable information (serialization) so prominent it dominates the brand.

Every unit has a unique serial number printed on it. If this unique number is printed large and prominently, the packaging looks different on every unit. The brand identity feels inconsistent.

Keep variable information (serial numbers, lot numbers) discrete. Emphasize the consistent elements (brand name, product benefit, visual identity) that make every unit feel like part of one brand.

The Bridge Between Compliance and Aesthetics

The best pharmaceutical packaging designers understand that serialization is not separate from design. It's part of the design problem.

You're not trying to hide compliance. You're not trying to make compliance look invisible. You're trying to integrate compliance into a coherent visual system where everything serves both regulatory requirement and brand intention.

A 2D barcode doesn't have to be ugly. It can be positioned, sized, and contextualized so it looks intentional. A serial number doesn't have to be cluttered visual noise. It can be typography that reinforces your brand's precision and professionalism.

Serialization is the opportunity to signal that this is authentic, traceable, legitimate pharmaceutical product. That's a brand advantage if you design it strategically.

FAQ

Q: What happens if I don't include serialization on my pharmaceutical packaging?

A: Your product is not legally compliant in regulated markets. Pharmacies may refuse to stock it. Regulatory authorities can issue warning letters or seize inventory. You're also at higher risk for counterfeiting. Serialization is mandatory, not optional.

Q: Can I use the same label design for all markets or do I need market-specific designs?

A: You likely need market-specific designs. Serialization requirements differ by market. Language requirements differ. The safest approach is market-specific designs that inherit from a master design system. Some elements can stay consistent (brand name, visual identity) while serialization and regulatory elements adapt to local requirements.

Q: How much of my label does a 2D barcode actually take up?

A: A Data Matrix code typically ranges from 8x8 mm to 25x25 mm. Smaller codes are harder to scan reliably. Larger codes use more label space. The standard is usually 12x12 mm to 15x15 mm, which is about 1 square inch on a typical pharmaceutical label. That's 8-12% of total label space if the label is 4"x3".

Q: Can I hide the 2D barcode on the back of my label?

A: You need to check your specific regulatory requirements. DSCSA requires the barcode be visible and scannable. Hiding it makes scanning difficult. FMD may have different requirements. Ask your regulatory specialist whether placement on front vs. back is allowable in your markets.

Q: What if my serialization system requires different barcode formats for different markets?

A: This is common. The U.S. accepts Data Matrix or GS1 linear barcodes. EU prefers Data Matrix. You'll need label designs that accommodate the preferred format for each market. Plan this into your design system from the beginning.

Q: How do I ensure my barcodes scan reliably in production?

A: Test with your actual printer, substrate, and printing process before committing to print runs. Have your serialization vendor provide barcode validation reports. Test scanning with actual pharmacy automation or regulatory scanning systems. Don't assume barcodes will work without testing.

Q: What if I'm selling OTC pharmaceuticals vs. Rx pharmaceuticals? Does serialization differ?

A: Yes, significantly. Rx pharmaceuticals generally face stricter serialization requirements. OTC pharmaceuticals in some markets have less stringent requirements or exemptions. EU FMD applies primarily to Rx medicines. Check your specific product category and market.

Q: Can I use variable data printing to handle serialization on-demand?

A: Yes, variable data printing (VDP) is actually the most common approach. Your base label design stays the same. Serial numbers, lot numbers, and expiry dates are printed variably based on production data. This requires close coordination between your design, your serialization system, and your printer.

Q: What information must appear in both human-readable and machine-readable (barcode) format?

A: Typically the product identifier, serial number, lot number, and expiry date. Some markets require additional data. Your serialization vendor and regulatory team should specify exactly which data elements need to appear in which formats.

Q: How do I know if a designer understands pharmaceutical serialization requirements?

A: Ask them about their experience with DSCSA compliance, FMD requirements, barcode testing, and variable data printing. Ask to see examples of labels they've designed that include 2D codes. Real pharmaceutical packaging designers know that serialization is a design constraint, not an afterthought.

Q: What if my contract manufacturer handles serialization? Do I still need to design around it?

A: Yes. Even if your CMO or contract packager handles the actual serialization printing, your brand must design the label accommodating serialization elements. You're responsible for ensuring the design is compliant and that serialization elements integrate visually with your brand identity.

I'm Tambi Haşpak, a brand strategist and creative director with an unfair advantage: I'm a pharmacist. I run a creative studio for cosmetics, supplements and beyond. 17+ years. Exclusively. I've designed pharmaceutical packaging for regulated markets, managed serialization compliance, and solved the design problem of making track-and-trace requirements feel like part of your brand, not a regulatory burden. When you're designing pharmaceutical packaging and need to integrate serialization requirements strategically, I can help you build a design system that is both compliant and coherent. Start by reading my pharmaceutical packaging design services and my work on pharmaceutical branding strategy to understand how compliance and aesthetics intersect.